StonvexLoading…
StonvexCore line items from APD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $3.23B | $6.27B | $3.10B | $12.04B | $8.87B |
Operating Income | Not available | $1.49B | $734.50M | $-877.00M | $-893.80M |
Net Income | Not available | $1.39B | $678.20M | $-394.50M | $-399.40M |
EPS (Diluted) | $3.37 | $6.23 | $3.04 | $-1.77 | $-1.79 |
Total Assets | Not available | $41.64B | $41.24B | $41.06B | $41.66B |
Total Liabilities | Not available | $23.49B | $23.40B | $23.71B | $23.89B |
Cash & Equivalents | Not available | $951.00M | $1.03B | $1.86B | $2.32B |
Free Cash Flow OCF − CapEx | Not available | $-354.40M | $-350.50M | $-3.77B | $-3.51B |
Shares Outstanding | Not available | 222.90M | 222.90M | 222.59M | 222.70M |